Multi-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas
Abstract Background Meningioma is a common primary central nervous system tumor that can cause a heavy burden on patients. Despite its well-established treatment modalities, pharmacological treatments are not sufficiently abundant. Therefore, we explored potential therapeutic targets for meningiomas...
Saved in:
| Main Authors: | Yongxue Li, Lihao Lin, Wenhui Zhang, Yan Wang, Haoyu Shen, Yi Guan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03318-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Breast Cancer and Meningioma Risk: A Mendelian Randomization Study
by: Jian‐Wei Huang, et al.
Published: (2025-03-01) -
Integrative Proteomics and Genomics Identify Novel Biomarkers and Therapeutic Targets in Vitiligo via Mendelian Randomization
by: Chenjue Yan, et al.
Published: (2025-06-01) -
Potential Causal Relationship Between Plasma and Cerebrospinal Fluid Metabolites and Meningioma: Two-Sample Mendelian Randomization Study
by: Du G, et al.
Published: (2025-07-01) -
Association between hypothyroidism and nephrotic syndrome: a bidirectional two-sample Mendelian randomization analysis
by: Can Liu, et al.
Published: (2024-12-01) -
Identification of prostate cancer potential therapeutic targets and virtual drug screening through combined Mendelian randomization study, Bayesian colocalization and molecular docking
by: Zilong Liang, et al.
Published: (2025-06-01)